Aroa Biosurgery Limited
AROAF
$0.35
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 50.19M | 48.65M | 46.44M | 44.11M | 42.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.19M | 48.65M | 46.44M | 44.11M | 42.12M |
| Cost of Revenue | 7.15M | 6.73M | 6.21M | 6.16M | 6.16M |
| Gross Profit | 43.04M | 41.93M | 40.23M | 37.95M | 35.96M |
| SG&A Expenses | 39.82M | 40.82M | 41.31M | 39.45M | 37.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -644.50K | -717.60K | -782.20K | -894.60K | -1.02M |
| Total Operating Expenses | 52.02M | 52.58M | 52.46M | 50.35M | 48.63M |
| Operating Income | -1.83M | -3.93M | -6.02M | -6.24M | -6.51M |
| Income Before Tax | -1.97M | -3.17M | -4.36M | -5.34M | -6.36M |
| Income Tax Expenses | 337.40K | 306.40K | 273.10K | 196.90K | 122.80K |
| Earnings from Continuing Operations | -2.30 | -3.48 | -4.63 | -5.53 | -6.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.30M | -3.48M | -4.63M | -5.53M | -6.49M |
| EBIT | -1.83M | -3.93M | -6.02M | -6.24M | -6.51M |
| EBITDA | 96.60K | -1.95M | -4.05M | -4.26M | -4.51M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.38B | 1.38B | 1.38B | 1.38B | 1.38B |
| Average Diluted Shares Outstanding | 1.38B | 1.38B | 1.38B | 1.38B | 1.38B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |